Johnson & Johnson Agrees to Buy Ollin Biosciences for Up to $3.33 Billion
Johnson & Johnson has agreed to acquire Ollin Biosciences in a deal valued at up to $3.33 billion.
Johnson & Johnson has agreed to acquire Ollin Biosciences in a deal valued at up to $3.33 billion.